论文部分内容阅读
目的:分析和探讨在十二指肠溃疡病症的临床治疗中,应用奥美拉唑、克拉霉素、阿莫西林三联疗法的临床疗效。方法:随机抽选十二指肠溃疡患者78例,按照入院时间将他们进行分组治疗(对照组患者39例,观察组患者39例)。采用奥美拉唑疗法对对照组的患者进行治疗,采用奥美拉唑、克拉霉素、阿莫西林三联疗法对观察组的患者进行治疗,并统计、比较和分析两组患者的临床治疗效果。结果:经过治疗,观察组患者在治疗后1周、2周时的血清指标水平明显低于对照组患者,且在腹痛消失时间、临床疗效以及复发率方面明显优于对照组,各项组间比较均具有统计学意义(P<0.05)。结论:奥美拉唑、克拉霉素、阿莫西林三联疗法是一种疗效显著的安全、理想的十二指肠溃疡临床治疗方法。
Objective: To analyze and discuss the clinical efficacy of omeprazole, clarithromycin and amoxicillin triple therapy in the clinical treatment of duodenal ulcer. Methods: A total of 78 patients with duodenal ulcer were randomly selected and divided into groups according to the time of admission (39 in the control group and 39 in the observation group). The patients in the control group were treated with omeprazole therapy. The patients in the observation group were treated with omeprazole, clarithromycin, and amoxicillin triple therapy, and the clinical effects of the two groups were statistically compared and analyzed . Results: After treatment, the serum level of the observation group was significantly lower than that of the control group at 1 week and 2 weeks after treatment, and was significantly better than the control group in the disappearance of abdominal pain, clinical efficacy and recurrence rate Comparison was statistically significant (P <0.05). Conclusion: Omeprazole, clarithromycin, amoxicillin triple therapy is a safe and effective clinical treatment of duodenal ulcer.